“Comparative Effectiveness and Safety of High-Intensity Statins (Atorvastatin vs Rosuvastatin) in Coronary Heart Disease Patients After Percutaneous Coronary Intervention (PCI) : A Literature Review” (2026) Journal of Pharmaceutical and Sciences, 9(3), pp. 2815–2826. doi:10.36490/journal-jps.com.v9i3.1676.